Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates
Medicinal Research Reviews · 2024
DOI: 10.1002/med.22032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2024. Verfasst von Venu Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Natural Products and Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir, India. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Drug Approval, Drug Discovery. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 263 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Natural products have always served as an important source of drugs for treating various diseases. Among various privileged natural product scaffolds, the benzopyrone class of compounds has a substantial presence among biologically active compounds. One of the pioneering anticoagulant drugs, warfarin approved in 1954 bears a benzo‐α‐pyrone (coumarin) nucleus. The widely investigated psoriasis drugs, methoxsalen, and trioxsalen, also contain a benzo‐α‐pyrone nucleus. Benzo‐γ‐pyrone (chromone) containing drugs, cromoglic acid, and pranlukast were approved as treatments for asthma in 1982 and 2007, respectively. Numerous other small molecules with a benzopyrone core are under clinical investigation. The present review discusses the discovery, absorption, distribution, metabolism, excretion properties, and synthetic approaches for the Food and Drug Administration‐approved and clinical‐stage benzopyrone class of compounds. The role of the pyrone core in biological activity has also been discussed. The present review unravels the potential of benzopyrone core in medicinal chemistry and drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Products and Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.
- Department of Natural Products and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.
ORCID-Profile: Sandip B Bharate
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Sharma, V., Sharma, A., Wadje, B. N., & Bharate, S. B. (2024). Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates. Medicinal Research Reviews. https://doi.org/10.1002/med.22032
Vancouver
Sharma V, Sharma A, Wadje BN, Bharate SB. Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates. Medicinal Research Reviews. 2024. doi:10.1002/med.22032
BibTeX
@article{Sharma2024,
author = {Sharma, Venu and Sharma, Ankita and Wadje, Bhagyashri N and Bharate, Sandip B},
title = {Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates},
journal = {Medicinal Research Reviews},
year = {2024},
doi = {10.1002/med.22032}
}
EUVIMED